Actos reduces the combined risk of nonfatal heart attacks.

Actos reduces the combined risk of nonfatal heart attacks, strokes in individuals with type-2 diabetes A report published in The Lancet implies that Takeda’s Actos , an oral glucose decreasing medication, significantly reduces the combined risk of non-fatal heart attacks, strokes and deaths by yet another 16 percent along with standard medicine, such as statins, fibrates, ACE inhibitors, beta blockers, various other glucose-lowering medications and anti-platelet medications, in patients with type-2 diabetes with high risk of cardiovascular disease. This means that for each and every 48 patients treated with Actos over 3 years one major cardiovascular event or loss of life could be prevented. Seeing pioglitazone improve these cardiovascular outcomes is an impressive result especially as these sufferers were already receiving standard treatments including the usage of lipid-modifying medications, anti-hypertensives, aspirin and additional glucose-lowering agents, stated Professor Ian Campbell, Consultant Physician at Victoria Hospital, Edinburgh, Scotland prescription medication .

It is believed that placing the small needles at factors along the pathways reduce pain and improve the healing process. Related StoriesAlexander Technique or acupuncture can reduce chronic throat painGlan Clwyd Medical center N Wales spend money on Esaote's G-Scan MRI unit for weight-bearing scanningFirst medical center installs Ortho Vision Analyzer The National Institute of Health has published a declaration concluding that acupuncture is effective for dealing with adults for nausea following chemotherapy and for discomfort after dental surgery. The agency also said that the therapy may be useful in treating additional health issues such as addiction, migraines, head aches, menstrual cramps, abdominal pain, tennis elbow, fibromyalgia, arthritis, low-back pain, carpal tunnel syndrome and asthma.